SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001404644-24-000010
Filing Date
2024-03-14
Accepted
2024-03-14 20:54:55
Documents
1
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710464082.html 4  
1 FORM 4 wk-form4_1710464082.xml 4 4029
  Complete submission text file 0001404644-24-000010.txt   5792
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH ST., STE. 505 NEW YORK NY 10011
Business Address
McMinn Rachel (Reporting) CIK: 0001606302 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 24752217